Biovica and Pelago Bioscience offer unique solution for improved drug development

  The biotech companies Pelago Bioscience and Biovica have agreed to collaborate in providing a common platform for faster and better evaluation of new oncology candidate drugs and medicines. Together the companies will provide a unique platform, correlating efficacy of novel oncology drugs with mode of action and target interaction evaluation. This solution offers the [...]

2015-09-07T08:00:55+00:00 September 7th, 2015 08:00|Regulatory|